US9913909 — Compositions of a polyorthoester and an aprotic solvent
Method of Use · Assigned to Heron Therapeutics LLC · Expires 2034-03-13 · 8y remaining
What this patent protects
This patent describes delivery systems and compositions that combine a biodegradable polymer, an aprotic solvent, and a drug, such as Bupivacaine Hydrochloride And Epinephrine.
USPTO Abstract
Delivery systems and compositions comprised of a biodegradable polyorthoester polymer, an aprotic solvent, and a drug are described. The solvent is selected to modulate release of drug from the composition, where, in some embodiments, the solvent is rapidly released after administration and provides a corresponding rapid rate of drug release. Alternatively, in other embodiments, the solvent is slowly released from the composition after its administration, and provides a correspondingly slow rate of drug release.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-3118 |
— | Bupivacaine Hydrochloride And Epinephrine |
U-3118 |
— | Bupivacaine Hydrochloride And Epinephrine |
U-3118 |
— | Bupivacaine Hydrochloride And Epinephrine |
U-3118 |
— | Bupivacaine Hydrochloride And Epinephrine |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.